• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

Turning Stem Cells into Cancer-Killing Warriors

RESEARCHERS FROM UCLA'S CANCER AND STEM-CELL CENTERS have demonstrated for the first time that blood stem cells can be engineered to create cancer-killing T-cells that seek out and attack a human melanoma. The researchers believe the approach could be useful in about 40 percent of Caucasians with this malignancy.

Done in mouse models, the study serves as the first proof-of-principle that blood stem cells, which make every type of cell found in the blood, can be genetically altered in a living organism to create an army of melanoma-fighting T-cells, says Jerome Zack, Ph.D., professor of medicine and microbiology, immunology and molecular genetics and a scientist with UCLA's Jonsson Comprehensive Cancer Center and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.

"We knew from previous studies that we could generate engineered T-cells, but would they work to fight cancer in a relevant model of human disease, such as melanoma?" asks Dr. Zack. "We found with this study that they do work in a human model to fight cancer, and it's a pretty exciting finding."

The study appeared in the online edition of the journal Proceedings of the National Academy of Sciences.

Researchers used a T-cell receptor — cloned by other scientists from a cancer patient — that seeks out an antigen expressed by a certain type of melanoma. They then genetically engineered the human-blood stem cells by importing genes for the T-cell receptor into the stem-cell nucleus using a viral vehicle. The genes integrate with the cell DNA and are permanently incorporated into the blood stem cells, theoretically enabling them to produce melanoma-fighting cells indefinitely and when needed, says Dimitrios N. Vatakis, the study's first author and an assistant researcher in Dr. Zack's lab.

"The nice thing about this approach is a few engineered stem cells can turn into an army of T-cells that will respond to the presence of this melanoma antigen," Vatakis says. "These cells can exist in the periphery of the blood, and if they detect the melanoma antigen, they can replicate to fight the cancer."

In the study, the engineered blood stem cells were placed into human thymus tissue that had been implanted in the mice, allowing Dr. Zack and his team to study the human immune system reaction to melanoma in a living organism. Over about six weeks, the engineered blood stem cells developed into a large population of mature, melanoma-specific T-cells that were able to target the right cancer cells.

The mice were then implanted with two types of melanoma tumors, one that expressed the antigen complex that attracts the engineered T-cells and one that did not. The engineered cells specifically went after the antigen-expressing melanoma, leaving the control tumor alone, Dr. Zack says.

This approach to immune system engineering has intriguing implications, Dr. Zack says. T-cells can be engineered to fight disease, but their function is not long-lasting in most cases, and more engineered T-cells ultimately are needed to sustain a response. This new approach engineers the cells that give rise to the T-cells so that "fresh" cancer-killing cells could be generated when needed, perhaps protecting against cancer recurrence later.


Previous
Heartfelt Award
Next
Tracking Teen Suicide


YOU ARE VIEWING

Winter/Spring 2012

Winter/Spring 2012
E-Brochure
Printable PDF
IN THIS ISSUE
  • The Invisible Backbone
  • Detecting Pancreatic Cancer in Saliva
  • Visualizing the Web of Depression
  • The Rhythm of Learning
  • UCLA in the Community
  • Fish Oil Lowers Prostate Risk
  • Older May Not Be Better
  • Heartfelt Award
  • Turning Stem Cells into Cancer-Killing Warriors
  • Tracking Teen Suicide
  • The Wakeful Brain
  • David T. Feinberg, M.D., M.B.A
  • Five-Star Care
  • A New Face for an Old Friend
  • Therapeutic Aesthetic
  • Culture of Caring
  • The Music of Medicine
  • Awards/Honors
  • Grants
  • Alumni Celebrate Life of Former Dean of Students
  • One-on-One: Jamie D. Feusner, M.D. ’99
  • Postcard from The Hood
  • MAA 2012 Reunion Weekend
  • MAA on the Road
  • Honoring the Visionaries in Our Community
  • Chairs of Distinction
  • Gifts
  • In Memoriam
  • Gift from the Heart
  • Events
  • A Vision Realized
  • The Healing Medicine of a Wet Nose
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth